Financials data is unavailable for this security.
View more
Year on year Chordate Medical Holding AB (publ) had net income fall 4.45% from a loss of 27.94m to a larger loss of 29.19m despite a 799.63% increase in revenues from 108.52k to 976.28k.
Gross margin | 219.20% |
---|---|
Net profit margin | -2,477.25% |
Operating margin | -2,517.41% |
Return on assets | -90.02% |
---|---|
Return on equity | -110.15% |
Return on investment | -110.15% |
More ▼
Cash flow in SEKView more
In 2023, Chordate Medical Holding AB (publ) increased its cash reserves by 130.01%, or 4.78m. Cash Flow from Financing totalled 33.20m or 3,400.71% of revenues. In addition the company used 27.26m for operations while cash used for investing totalled 1.16m.
Cash flow per share | -37.85 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 21.16 |
---|---|
Tangible book value per share | 12.18 |
More ▼
Balance sheet in SEKView more
Current ratio | 2.65 |
---|---|
Quick ratio | 2.34 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼